Fagron SA FAGR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €18.00
- Day Range
- €17.92–18.12
- 52-Week Range
- €15.45–20.05
- Bid/Ask
- €17.90 / €18.36
- Market Cap
- €1.31 Bil
- Volume/Avg
- 75,926 / 53,688
Key Statistics
- Price/Earnings (Normalized)
- 15.59
- Price/Sales
- 1.60
- Dividend Yield (Trailing)
- 1.67%
- Dividend Yield (Forward)
- 1.67%
- Total Yield
- 1.84%
Company Profile
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,567
- Website
- https://www.fagron.com
Comparables
Valuation
|
Metric
|
FAGR
|
APH
|
605116
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.59 | 8.70 | 30.07 |
Price/Book Value | 2.77 | 1.09 | 4.70 |
Price/Sales | 1.60 | 1.26 | 6.90 |
Price/Cash Flow | 11.15 | 6.54 | 20.39 |
Price/Earnings
FAGR
APH
605116
Financial Strength
|
Metric
|
FAGR
|
APH
|
605116
|
|---|---|---|---|
Quick Ratio | 1.08 | 1.97 | 1.29 |
Current Ratio | 1.74 | 2.93 | 2.22 |
Interest Coverage | 6.43 | −3.96 | 163.49 |
Quick Ratio
FAGR
APH
605116
Profitability
|
Metric
|
FAGR
|
APH
|
605116
|
|---|---|---|---|
Return on Assets (Normalized) | 8.12% | 5.83% | 14.01% |
Return on Equity (Normalized) | 18.51% | 11.32% | 18.41% |
Return on Invested Capital (Normalized) | 11.07% | 9.14% | 16.29% |
Return on Assets
FAGR
APH
605116
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Wmvwmftnsg | Prl | $86.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Gdvsmlfmny | Ynjqg | $74.3 Bil | |||
| Haleon PLC ADR
HLN
| Cxnmrpv | Mrzc | $45.9 Bil | |||
| Viatris Inc
VTRS
| Fzvwxkq | Csvq | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Msrsvvnch | Fvpq | $13.2 Bil | |||
| Catalent Inc
CTLT
| Hgpgksqdy | Fnjcs | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Smxtbpm | Pzjvyx | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Xlywgcqm | Lzcq | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Gwyjnpth | Zfgj | $2.4 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Qkqwpgvtp | Vmvq | $2.2 Bil |
United States